Overview
A drug is one drug product, whatever name each company uses for it: its INN, research codes and brand names. The originator, its partners, licensees and parent all list the same drug, and each of their programs carries the samedrug_id. A biosimilar or generic is a separate drug.
Questions this dataset answers:
- Which companies hold rights to inclisiran, and how far has each taken it?
- What is
TEV-48574called now, and who develops it? - Which of Merck’s drugs are shared with a partner?
Coverage
Every program of a named drug has a
drug_id. A program whose company does not
name its asset (drug is Undisclosed) has none.
Key fields
GET /v1/drugs/{drug_id} adds programs[]: the drug’s programs across
companies, as light program rows.
Endpoints
Filters
Without
q, drugs are listed by phase, most advanced first.
Look up a drug by any name
A brand, code or INN returns the same drug with every company that holds it.Example response (trimmed)
Get one drug with its programs
Example response (trimmed)
A company’s shared drugs
company_id with multi_company=true lists the company’s drugs that other
companies also hold: partnered, licensed or co-developed assets.
Example response (trimmed)
A brand name is found once one of the drug’s companies uses it. Search the
INN or a research code as well when a brand returns nothing.